aldesleukin
Showing 1 - 25 of 188
Solid Tumor Trial in Seoul (TASO-001((TGF-ß2 targeting anti-sense oligonucleotide), Aldesleukin)
Recruiting
- Solid Tumor
- TASO-001((TGF-β2 targeting anti-sense oligonucleotide)
- Aldesleukin
-
Seoul, Korea, Republic ofSeoul National University Hospital
Jan 31, 2023
Metastatic Melanoma, Advanced Locoregional Melanoma, Metastatic Renal Cell Carcinoma Trial run by the National Cancer Institute
Recruiting
- Metastatic Melanoma
- +3 more
- Pembrolizumab
- Aldesleukin
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 20, 2022
Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States
Active, not recruiting
- Clear Cell Renal Cell Carcinoma
- +3 more
- Aldesleukin
- +6 more
-
Los Angeles, California
- +3 more
Nov 16, 2022
Alzheimer Trial in Houston (Aldesleukin)
Completed
- Alzheimer Disease
- Aldesleukin
-
Houston, TexasAlireza Faridar
Apr 19, 2023
Metastatic Malignant Tumor in the Liver, Metastatic Uveal Melanoma Trial in Houston (Aldesleukin, Autologous CD8+
Active, not recruiting
- Metastatic Malignant Neoplasm in the Liver
- Metastatic Uveal Melanoma
- Aldesleukin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Jan 20, 2023
Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Houston (biological,
Completed
- Metastatic Melanoma
- +3 more
- Aldesleukin
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Oct 27, 2022
HIV Trial run by the NIAID (Aldesleukin)
Completed
- HIV Infections
- Aldesleukin
-
Bethesda, MarylandNatl Inst of Allergy & Infect Dis / Cln Ctr
Oct 27, 2021
Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer Trial run by the National Cancer Institute
Recruiting
- Metastatic Colorectal Cancer
- +4 more
- Young TIL
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
COL6A3 Positive, HLA-A*0201 Positive Cells Present, PRAME Positive Trial in Houston (biological, drug, procedure)
Active, not recruiting
- COL6A3 Positive
- +3 more
- Aldesleukin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Sep 22, 2022
Clinical Stage IV Gastric Cancer AJCC v8, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Rochester
Not yet recruiting
- Clinical Stage IV Gastric Cancer AJCC v8
- +4 more
- Aldesleukin
- +10 more
-
Rochester, MinnesotaMayo Clinic in Rochester
Apr 5, 2023
Metastatic Melanoma Trial run by the National Cancer Institute (NCI) (Aldesleukin, Fludarabine, Cyclophosphamide)
Completed
- Metastatic Melanoma
- Aldesleukin
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 21, 2022
Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston
Active, not recruiting
- Metastatic Melanoma
- +2 more
- Aldesleukin
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Leukemia Trial (biological, drug, procedure, radiation)
Active, not recruiting
- Leukemia
- aldesleukin
- +9 more
- (no location specified)
Feb 17, 2022
Cervical Cancer, Renal Cancer, Urothelial Cancer Trial run by the NCI (Anti-MAGE-A3-DP4 T Cell Receptor (TCR) Peripheral Blood
Completed
- Cervical Cancer
- +4 more
- Anti-MAGE-A3-DP4 T Cell Receptor (TCR) Peripheral Blood Lymphocytes (PBL)
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 2, 2022
Advanced Solid Tumor, Metastatic Cancer Trial in Miranda, Clayton, Heidelberg (AU-007, Aldesleukin)
Recruiting
- Advanced Solid Tumor
- Metastatic Cancer
- AU-007
- Aldesleukin
-
Miranda, New South Wales, Australia
- +2 more
Jun 10, 2022
Endocrine/Neuroendocrine, NSCLC, Breast Cancer Trial run by the National Cancer Institute (NCI) (Fludarabine, Cyclophosphamide,
Recruiting
- Endocrine/Neuroendocrine
- +4 more
- Fludarabine
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Metastatic Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in Houston (biological, drug, other)
Active, not recruiting
- Metastatic Melanoma
- Stage IV Cutaneous Melanoma AJCC v6 and v7
- Aldesleukin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
HLA-A*0201 Positive Cells Present, NY-ESO-1 Positive Tumor Cells Present, Recurrent Myxoid Liposarcoma Trial in Houston
Active, not recruiting
- HLA-A*0201 Positive Cells Present
- +3 more
- Aldesleukin
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Metastatic Melanoma, Skin Cancer Trial run by the National Cancer Institute (NCI) (drug, biological, radiation)
Active, not recruiting
- Metastatic Melanoma
- Skin Cancer
- Aldesleukin
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
NSCLC, Metastatic Non Small Cell Lung Cancer, Stage IV NSCLC Trial in Duarte, Minneapolis (Fludarabine, Cyclophosphamide, CISH
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- +5 more
- Fludarabine
- +4 more
-
Duarte, California
- +1 more
Dec 7, 2022
Metastatic Renal Cell Carcinoma, Metastatic Melanoma Trial in United States (Aldesleukin)
Completed
- Metastatic Renal Cell Carcinoma
- Metastatic Melanoma
- Aldesleukin
-
Los Angeles, California
- +3 more
Jun 4, 2021
Covid19 Trial in Ribeirão Preto, Santo André (Ixekizumab, Aldesleukin, Colchicine)
Completed
- Covid19
- Ixekizumab
- +3 more
-
Ribeirão Preto, SP, Brazil
- +1 more
Jul 26, 2022
Type1 Diabetes Trial in United Kingdom (Aldesleukin, Placebo)
Active, not recruiting
- Type1 Diabetes
- Aldesleukin
- Placebo
-
Oxford, Oxfordshire, United Kingdom
- +4 more
Dec 15, 2021
Malignant Tumor Trial in Los Angeles (biological, drug, other, radiation, procedure)
Active, not recruiting
- Malignant Neoplasm
- aldesleukin
- +7 more
-
Los Angeles, CaliforniaUniversity of California at Los Angeles (UCLA )
Dec 1, 2022
HIV Trial in Stanford (Zidovudine, Aldesleukin)
Completed
- HIV Infections
- Zidovudine
- Aldesleukin
-
Stanford, CaliforniaStanford Univ School of Medicine
Oct 27, 2021